UNIGE document Scientific Article
previous document  unige:10617  next document
add to browser collection

Impact of species-dependent differences on screening, design, and development of MAO B inhibitors

Novaroli, L.
Favre, Elisabeth
Carotti, Angelo
Leonetti, F.
Catto, M.
show hidden authors show all authors [1 - 9]
Published in Journal of Medicinal Chemistry. 2006, vol. 49, no. 21, p. 6264-6272
Abstract The impact of species-dependent differences between human and rat MAO B on inhibitor screening was evidenced for two classes of compounds, coumarin and 5H-indeno[1,2-c]pyridazin-5-one derivatives. All examined compounds have shown a greater inhibitor potency toward human MAO B than toward rat MAO B. Moreover, no correlation was found between human and rat pIC(50) values. These divergences have important implications for the design and development of drugs involved in the MAO B metabolic pathway, suggesting that results obtained using rat enzyme cannot be extrapolated to human CNS, a priori. Indeed, the selection of a hit compound for lead generation could be different using human rather than rat enzyme. Moreover, the influence of substituents on the in vitro inhibition of human MAO B was markedly different between homogeneous series of coumarin and 5H-indeno[1,2-c]pyridazin-5-one derivatives, suggesting different binding modes, a hypothesis clearly supported by molecular docking simulations of inhibitors into the active site of human MAO B.
Keywords AnimalsBinding SitesCoumarins/*chemical synthesis/chemistry/pharmacologyDrug DesignHumansIndenes/*chemical synthesis/chemistry/pharmacologyLigandsMitochondrial Membranes/drug effects/enzymologyModels, MolecularMolecular StructureMonoamine Oxidase/*metabolismMonoamine Oxidase Inhibitors/*chemical synthesis/chemistry/pharmacologyProtein BindingPyridazines/*chemical synthesis/chemistry/pharmacologyRatsSpecies SpecificityStructure-Activity Relationship
PMID: 17034132
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://pubs.acs.org/doi/pdfplus/10.1021/jm060441e
(ISO format)
NOVAROLI, L. et al. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors. In: Journal of Medicinal Chemistry, 2006, vol. 49, n° 21, p. 6264-6272. https://archive-ouverte.unige.ch/unige:10617

215 hits

0 download


Deposited on : 2010-08-06

Export document
Format :
Citation style :